Report Detail

Other Global Monoclonal Mouse Antibody Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • RnM3023303
  • |
  • 26 February, 2019
  • |
  • Global
  • |
  • 139 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.

Scope of the Report:
For antibody discovery, mice are one of the most important sources. They produce similar antibody isotypes with human, including IgA, IgD, IgE, IgG and IgM. Compared with the subclasses of human antibody isotypes, mice contain only one IgA class and the IgG subclasses are known as IgG1, IgG2a, IgG2b and IgG3. In addition, laboratory mice can induce a good immune response to a great range of antigens, even those highly homological human proteins. Moreover, some treatments that unacceptable for humans can also be aboveboard applied for mice with results which are analogous to that from humans. Therefore, the development of mouse monoclonal antibodies is a common choice for a variety of therapeutics and pathology researches. Up to now, the rapid development of therapeutic antibody in the pharmaceutical industry has enabled the mice to play an important role in both monoclonal antibodies discovery and the pre-clinical assessment.
The key players are Roche, Johnson & Johnson, Merck, Novartis, AbbVie, Amgen, Pfizer, Bayer, Lilly, Bristol-Myers Squibb, GlaxoSmithKline, Biogen, AstraZeneca, Sanofi, Alexion Pharmaceuticals, Seattle Genetics and so on.
The leading companies own the advantages on better performance, more abundant product’s types, better technical and impeccable after-sales service. Consequently, they take the majority of the market share of high-end market. Looking to the future years, the slow downward price trend in recent years will maintain. As competition intensifies, prices gap between different brands will go narrowing. Similarly, there will be fluctuation in gross margin.
The global Monoclonal Mouse Antibody market is valued at 7330 million USD in 2018 and is expected to reach 9990 million USD by the end of 2024, growing at a CAGR of 5.3% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Monoclonal Mouse Antibody.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Monoclonal Mouse Antibody market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Monoclonal Mouse Antibody market by product type and applications/end industries.

Market Segment by Companies, this report covers
Roche
Johnson & Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
IgM
IgG
IgA
Other

Market Segment by Applications, can be divided into
Therapeutic
Research
Diagnostic


Table of Contents

    1 Monoclonal Mouse Antibody Market Overview

    • 1.1 Product Overview and Scope of Monoclonal Mouse Antibody
    • 1.2 Classification of Monoclonal Mouse Antibody by Types
      • 1.2.1 Global Monoclonal Mouse Antibody Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Monoclonal Mouse Antibody Revenue Market Share by Types in 2018
      • 1.2.3 IgM
      • 1.2.4 IgG
      • 1.2.5 IgA
      • 1.2.6 Other
    • 1.3 Global Monoclonal Mouse Antibody Market by Application
      • 1.3.1 Global Monoclonal Mouse Antibody Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Therapeutic
      • 1.3.3 Research
      • 1.3.4 Diagnostic
    • 1.4 Global Monoclonal Mouse Antibody Market by Regions
      • 1.4.1 Global Monoclonal Mouse Antibody Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Monoclonal Mouse Antibody Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Monoclonal Mouse Antibody Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Monoclonal Mouse Antibody Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Monoclonal Mouse Antibody Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Monoclonal Mouse Antibody Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Monoclonal Mouse Antibody (2014-2024)

    2 Manufacturers Profiles

    • 2.1 Roche
      • 2.1.1 Business Overview
      • 2.1.2 Monoclonal Mouse Antibody Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Roche Monoclonal Mouse Antibody Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Johnson & Johnson
      • 2.2.1 Business Overview
      • 2.2.2 Monoclonal Mouse Antibody Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Johnson & Johnson Monoclonal Mouse Antibody Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Merck
      • 2.3.1 Business Overview
      • 2.3.2 Monoclonal Mouse Antibody Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Merck Monoclonal Mouse Antibody Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Novartis
      • 2.4.1 Business Overview
      • 2.4.2 Monoclonal Mouse Antibody Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Novartis Monoclonal Mouse Antibody Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 AbbVie
      • 2.5.1 Business Overview
      • 2.5.2 Monoclonal Mouse Antibody Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 AbbVie Monoclonal Mouse Antibody Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Amgen
      • 2.6.1 Business Overview
      • 2.6.2 Monoclonal Mouse Antibody Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Amgen Monoclonal Mouse Antibody Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Pfizer
      • 2.7.1 Business Overview
      • 2.7.2 Monoclonal Mouse Antibody Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Pfizer Monoclonal Mouse Antibody Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Bayer
      • 2.8.1 Business Overview
      • 2.8.2 Monoclonal Mouse Antibody Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Bayer Monoclonal Mouse Antibody Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Lilly
      • 2.9.1 Business Overview
      • 2.9.2 Monoclonal Mouse Antibody Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Lilly Monoclonal Mouse Antibody Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Bristol-Myers Squibb
      • 2.10.1 Business Overview
      • 2.10.2 Monoclonal Mouse Antibody Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Bristol-Myers Squibb Monoclonal Mouse Antibody Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 GlaxoSmithKline
      • 2.11.1 Business Overview
      • 2.11.2 Monoclonal Mouse Antibody Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 GlaxoSmithKline Monoclonal Mouse Antibody Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Biogen
      • 2.12.1 Business Overview
      • 2.12.2 Monoclonal Mouse Antibody Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Biogen Monoclonal Mouse Antibody Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 AstraZeneca
      • 2.13.1 Business Overview
      • 2.13.2 Monoclonal Mouse Antibody Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 AstraZeneca Monoclonal Mouse Antibody Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Sanofi
      • 2.14.1 Business Overview
      • 2.14.2 Monoclonal Mouse Antibody Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Sanofi Monoclonal Mouse Antibody Revenue, Gross Margin and Market Share (2017-2018)
    • 2.15 Alexion Pharmaceuticals
      • 2.15.1 Business Overview
      • 2.15.2 Monoclonal Mouse Antibody Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 Alexion Pharmaceuticals Monoclonal Mouse Antibody Revenue, Gross Margin and Market Share (2017-2018)
    • 2.16 Seattle Genetics
      • 2.16.1 Business Overview
      • 2.16.2 Monoclonal Mouse Antibody Type and Applications
        • 2.16.2.1 Product A
        • 2.16.2.2 Product B
      • 2.16.3 Seattle Genetics Monoclonal Mouse Antibody Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Monoclonal Mouse Antibody Market Competition, by Players

    • 3.1 Global Monoclonal Mouse Antibody Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Monoclonal Mouse Antibody Players Market Share
      • 3.2.2 Top 10 Monoclonal Mouse Antibody Players Market Share
    • 3.3 Market Competition Trend

    4 Global Monoclonal Mouse Antibody Market Size by Regions

    • 4.1 Global Monoclonal Mouse Antibody Revenue and Market Share by Regions
    • 4.2 North America Monoclonal Mouse Antibody Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Monoclonal Mouse Antibody Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Monoclonal Mouse Antibody Revenue and Growth Rate (2014-2019)
    • 4.5 South America Monoclonal Mouse Antibody Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Monoclonal Mouse Antibody Revenue and Growth Rate (2014-2019)

    5 North America Monoclonal Mouse Antibody Revenue by Countries

    • 5.1 North America Monoclonal Mouse Antibody Revenue by Countries (2014-2019)
    • 5.2 USA Monoclonal Mouse Antibody Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Monoclonal Mouse Antibody Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Monoclonal Mouse Antibody Revenue and Growth Rate (2014-2019)

    6 Europe Monoclonal Mouse Antibody Revenue by Countries

    • 6.1 Europe Monoclonal Mouse Antibody Revenue by Countries (2014-2019)
    • 6.2 Germany Monoclonal Mouse Antibody Revenue and Growth Rate (2014-2019)
    • 6.3 UK Monoclonal Mouse Antibody Revenue and Growth Rate (2014-2019)
    • 6.4 France Monoclonal Mouse Antibody Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Monoclonal Mouse Antibody Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Monoclonal Mouse Antibody Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Monoclonal Mouse Antibody Revenue by Countries

    • 7.1 Asia-Pacific Monoclonal Mouse Antibody Revenue by Countries (2014-2019)
    • 7.2 China Monoclonal Mouse Antibody Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Monoclonal Mouse Antibody Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Monoclonal Mouse Antibody Revenue and Growth Rate (2014-2019)
    • 7.5 India Monoclonal Mouse Antibody Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Monoclonal Mouse Antibody Revenue and Growth Rate (2014-2019)

    8 South America Monoclonal Mouse Antibody Revenue by Countries

    • 8.1 South America Monoclonal Mouse Antibody Revenue by Countries (2014-2019)
    • 8.2 Brazil Monoclonal Mouse Antibody Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Monoclonal Mouse Antibody Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Monoclonal Mouse Antibody Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Monoclonal Mouse Antibody by Countries

    • 9.1 Middle East and Africa Monoclonal Mouse Antibody Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Monoclonal Mouse Antibody Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Monoclonal Mouse Antibody Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Monoclonal Mouse Antibody Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Monoclonal Mouse Antibody Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Monoclonal Mouse Antibody Revenue and Growth Rate (2014-2019)

    10 Global Monoclonal Mouse Antibody Market Segment by Type

    • 10.1 Global Monoclonal Mouse Antibody Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Monoclonal Mouse Antibody Market Forecast by Type (2019-2024)
    • 10.3 IgM Revenue Growth Rate (2014-2024)
    • 10.4 IgG Revenue Growth Rate (2014-2024)
    • 10.5 IgA Revenue Growth Rate (2014-2024)
    • 10.6 Other Revenue Growth Rate (2014-2024)

    11 Global Monoclonal Mouse Antibody Market Segment by Application

    • 11.1 Global Monoclonal Mouse Antibody Revenue Market Share by Application (2014-2019)
    • 11.2 Monoclonal Mouse Antibody Market Forecast by Application (2019-2024)
    • 11.3 Therapeutic Revenue Growth (2014-2019)
    • 11.4 Research Revenue Growth (2014-2019)
    • 11.5 Diagnostic Revenue Growth (2014-2019)

    12 Global Monoclonal Mouse Antibody Market Size Forecast (2019-2024)

    • 12.1 Global Monoclonal Mouse Antibody Market Size Forecast (2019-2024)
    • 12.2 Global Monoclonal Mouse Antibody Market Forecast by Regions (2019-2024)
    • 12.3 North America Monoclonal Mouse Antibody Revenue Market Forecast (2019-2024)
    • 12.4 Europe Monoclonal Mouse Antibody Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Monoclonal Mouse Antibody Revenue Market Forecast (2019-2024)
    • 12.6 South America Monoclonal Mouse Antibody Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Monoclonal Mouse Antibody Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Summary:
      Get latest Market Research Reports on Monoclonal Mouse Antibody . Industry analysis & Market Report on Monoclonal Mouse Antibody is a syndicated market report, published as Global Monoclonal Mouse Antibody Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Monoclonal Mouse Antibody market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,738.76
      4,108.14
      5,477.52
      3,205.08
      4,807.62
      6,410.16
      543,158.40
      814,737.60
      1,086,316.80
      289,953.60
      434,930.40
      579,907.20
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report